LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.31623
 45.61 770.25 1380 5813 0.2374 0.2214
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 45.61 770.25 1124 5813 0.1934 0.1384
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 47.83 770.25 1320 6223 0.2121 0.1957
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 47.83 770.25 1148 6223 0.1845 0.1416
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 50.05 770.25 1428 6629 0.2154 0.2199
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 50.05 770.25 1214 6629 0.1831 0.1578
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 52.27 770.25 1345 7058 0.1905 0.1906
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 52.27 770.25 1151 7058 0.1631 0.1339
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 54.49 770.25 1517 7555 0.2008 0.2285
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 54.49 770.25 1279 7555 0.1693 0.1664
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 56.71 770.25 1446 8001 0.1807 0.2050
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 56.71 770.25 1359 8001 0.1698 0.1831
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 58.94 770.25 1525 8444 0.1806 0.2186
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 58.94 770.25 1330 8444 0.1575 0.1713
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 61.16 770.25 1561 8892 0.1756 0.2216
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 61.16 770.25 1252 8892 0.1408 0.1476
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 63.39 770.25 1592 9326 0.1707 0.2236
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 63.39 770.25 1443 9326 0.1547 0.1906
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 65.61 770.25 1509 9736 0.1550 0.2017
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 65.61 770.25 1390 9736 0.1428 0.1750
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 67.83 770.25 1571 10078 0.1559 0.2118
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 67.83 770.25 1372 10078 0.1361 0.1684
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 70.05 770.25 1667 10413 0.1601 0.2281
MN20160304_L02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 70.05 770.25 1678 10413 0.1611 0.2303
MN20160304_L02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 72.27 770.25 1724 10730 0.1607 0.2362
MN20160304_L02
E08